Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share
Portfolio Pulse from
Quest Diagnostics reported strong financial results for Q4 and full year 2024, with significant revenue and EPS growth. The company also increased its quarterly dividend by 6.7% and provided positive guidance for 2025.
January 30, 2025 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics reported a 14.5% increase in Q4 revenues and a 14.7% increase in EPS. The company also raised its quarterly dividend by 6.7% and provided positive EPS guidance for 2025.
The strong financial performance in Q4 and full year 2024, along with the dividend increase and positive guidance for 2025, are likely to boost investor confidence and positively impact DGX's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100